[SCHEDULE 13G/A] INTEST CORP Amended Passive Investment Disclosure
Rhea-AI Filing Summary
inTEST Corp ownership filing: an amendment to a Schedule 13G/A by The Vanguard Group states it beneficially owns 0 shares of inTEST Corp common stock, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries or business divisions to report holdings separately, and affirms those entities now report disaggregated beneficial ownership in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership following internal disaggregation.
The filing explicitly lists 0 shares and 0% beneficial ownership for The Vanguard Group in inTEST Corp. The disclosure includes a note that subsidiaries/divisions now report separately under SEC Release No. 34-39538, which explains the administrative change in reporting structure.
Cash‑flow treatment and any specific subsidiary holdings are not disclosed in the excerpt; subsequent filings by the disaggregated entities would show actual holdings if present.
Amendment documents compliance with SEC disaggregation guidance.
The amendment cites SEC Release No. 34-39538 and states the realignment caused separate reporting by subsidiaries or business divisions. This is a procedural corrective filing to reflect organizational changes rather than an economic transaction in the issuer's securities.
Investors seeking holdings detail should review filings from the named subsidiaries or business divisions for their separate positions.